Lufax Faces Class Action Lawsuit from Investors
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 09 2026
0mins
Should l Buy LU?
Source: PRnewswire
- Class Action Initiated: Lufax is facing a class action lawsuit for securities transactions between April 7, 2023, and January 26, 2025, as investors suffered losses due to undisclosed related-party transactions, indicating potential significant legal liabilities ahead.
- Auditor Change Impact: The announcement on January 27, 2025, regarding the removal of PwC as auditor led to a nearly 14% drop in share price that day, reflecting severe market concerns over the company's financial transparency and governance.
- Lack of Internal Controls: The lawsuit alleges that Lufax lacked adequate internal controls, resulting in materially misstated financial statements, which undermines investor confidence in the company's financial health and could hinder future fundraising efforts.
- Investigation and Compensation Call: Hagens Berman is investigating whether Lufax intentionally violated accounting rules, urging affected investors to submit claims, highlighting deep concerns regarding the company's governance and compliance practices.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LU
About LU
LUFAX HOLDING LTD is a holding company mainly engaged in providing financial services for small and micro enterprises. The Company's core retail credit enablement business includes bank-funded loans, trust-funded loans and consumer finance loans. The Company is also engaged in wealth management and providing access to financial products and services. The Company conducts the business through its subsidiaries.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Class Action Initiated: Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Lufax for investors who purchased securities between April 7, 2023, and January 26, 2025, seeking damages for losses incurred due to false statements.
- Allegation Details: The lawsuit alleges that Lufax failed to disclose inadequate internal controls and materially misstated financial results during the class period, misleading investors regarding the company's business and prospects, thereby harming their legal rights.
- Investor Rights Protection: Investors must apply by May 20, 2026, to be appointed as lead plaintiff in the lawsuit to protect their rights, with Bragar Eagel & Squire offering free consultations and encouraging affected investors to reach out.
- Law Firm Background: Bragar Eagel & Squire, P.C. is a nationally recognized law firm specializing in securities, derivative, and commercial litigation, with extensive litigation experience dedicated to providing legal support for investors.
See More
- Class Action Initiated: Pomerantz LLP has filed a class action lawsuit against Lufax, alleging securities fraud and other unlawful business practices by the company and certain executives, with investors needing to apply as Lead Plaintiffs by May 20, 2026, highlighting serious concerns over corporate governance and transparency.
- Auditor Change Controversy: On January 27, 2025, Lufax announced plans to replace its auditor, PricewaterhouseCoopers, due to significant concerns regarding the company's financial disclosures for 2022 and 2023, leading to a loss of reliance on the audit opinions, which has raised red flags in the market.
- Stock Price Volatility: Following the auditor change announcement, Lufax's American Depositary Shares plummeted nearly 22% over three trading sessions, reflecting deep investor concerns about the company's financial health and potentially impacting its future fundraising capabilities.
- Law Firm Background: Pomerantz LLP is a prominent firm in securities class litigation, established over 85 years ago, focusing on advocating for victims of securities fraud, with a track record of multimillion-dollar recoveries for class members, indicating strong legal support for the plaintiffs in this case.
See More
- Lawsuit Background: Lufax (NYSE:LU) is facing a class action lawsuit for securities transactions between April 7, 2023, and January 26, 2025, as investors suffered significant losses due to potential undisclosed related-party transactions, raising serious concerns about the company's financial transparency.
- Auditor Removal: On January 27, 2025, Lufax announced the removal of PricewaterhouseCoopers as its auditor due to concerns over undisclosed related-party transactions, leading to a nearly 14% drop in share price that day, indicating a severe loss of market confidence in its financial reporting.
- Internal Control Deficiencies: The class action alleges that Lufax lacked adequate internal controls and materially misstated its financial results, with investors learning the truth on January 27, 2025, prompting a swift market reaction that heightened concerns over corporate governance.
- Investigation and Consequences: Hagens Berman is investigating whether Lufax intentionally violated accounting rules and disclosure requirements, and if confirmed, this could lead to broader legal liabilities and financial losses, significantly impacting the company's future operations and investor confidence.
See More
- Lawsuit Background: Lufax is proposing to replace its auditor, PwC, due to significant concerns regarding its financial disclosures, leading to unreliability in its 2022 and 2023 reports, which has severely impacted investors.
- Stock Price Impact: Following the announcement on January 27, 2025, Lufax's stock price fell by $0.40, or 13.8%, closing at $2.49 per share, directly affecting investor confidence and asset value.
- Allegations of Financial Misstatements: The class action lawsuit alleges that Lufax made materially false and misleading statements throughout the Class Period, failing to disclose inadequate internal controls and materially misstated financial results, misleading investors about the company's prospects.
- Legal Action Deadline: Investors must file a motion by May 20, 2026, to request appointment as lead plaintiff in this class action lawsuit to seek compensation for their investment losses, ensuring their legal rights are protected.
See More
- Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Lufax Holding Ltd, aiming to recover damages for investors who purchased securities between April 7, 2023, and January 26, 2025, highlighting serious concerns over the company's financial transparency.
- Allegations Detailed: The complaint alleges that Lufax lacked adequate internal controls and materially misstated financial results during the class period, leading to misleading statements about its business and prospects, which could significantly impact investor decisions and confidence.
- Investor Participation Opportunity: Affected investors have until May 20, 2026, to request to be appointed as lead plaintiff, indicating the firm's commitment to protecting investor rights and providing a legal avenue for potential compensation.
- Law Firm Background: Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that has recovered hundreds of millions for investors, showcasing its expertise and successful track record in securities fraud class actions.
See More
- Financial Misstatements: Lufax's reported net profit for 2022 was overstated by RMB 917 million, with an additional RMB 81.4 million for 2023, leading institutional investors to assess potential legal liabilities and loss recovery options.
- Audit Opinion Withdrawal: PricewaterhouseCoopers withdrew its audit opinions for 2022 and 2023 due to concerns over undisclosed related party transactions, intensifying investor worries about the company's financial transparency.
- Investor Responsibilities: Institutional investors holding Lufax shares must evaluate lead plaintiff opportunities in the class action to ensure effective representation of all shareholders and avoid fiduciary duty issues arising from inaction.
- Shareholder Value Erosion: The chain of disclosures triggered by audit issues led to significant shareholder value erosion during consecutive trading sessions in January 2025, necessitating an assessment of tracking errors and benchmark deviations in institutional portfolios.
See More











